RNF213 and multiminicore myopathy: These 1069-target genes included genes known to be associated with MMD [3, 4, 27], such as RNF213, fibroblast growth factors (FGF2, 7, 14, and 17), hepatocyte growth factor (HGF), platelet derived growth factor B (PDGFB), tumor transforming growth factor beta receptors (TGFBR1 and 2), tumor necrosis factor superfamily member genes (TNFSF4 and 12), and vascular endothelial growth factor A (VEGF A).